Wellstone Receives FTC Testing Facility Results DURHAM, N.C., March 23 /PRNewswire-FirstCall/ -- Wellstone Filters (OTC:WLSF) (BULLETIN BOARD: WLSF) announced that it has received results from an independent FTC testing facility that confirm the Company's expectations for their patented filter technology. Test results showed significant reductions in tar and nicotine and similar reductions of other classes of known carcinogens. "We are delighted with the results and will go into production immediately," stated CEO L.J. Hand. Wellstone believes that its patented filter formulation removes tars and certain carcinogens, without compromising taste. However, any claim as to the benefit of any Wellstone cigarette to be sold will be made within the parameters prescribed by the Federal Trade Commission. Wellstone emphasizes that NO cigarette is safe. This corporate communication by Wellstone is not intended to induce any person to purchase future Wellstone tobacco products. ABOUT THE COMPANY Wellstone Filters, Inc. has developed and patented filter material that removes certain carcinogens and other toxins produced when tobacco is smoked -- without removing the compounds thought to be associated with the pleasurable effects of smoking. Wellstone seeks to promote material for cigarette filters that will enable cigarette manufacturers to provide consumers with an equally enjoyable cigarette with substantially fewer carcinogens. For more information, please see http://www.wellstonefilters.com/ or call Investor relations at 303-620-9194. In addition, all current shareholders, and interested parties should sign into our private Corporate Guest Book, http://www.corporateguestbook.com/?WLSF to receive timely updates and information on any future developments as they happen. Note: Except for the historical information contained herein, this new release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third- party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by Wellstone with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of Wellstone as of the date of this release. Wellstone and its managers and agents undertake no obligation to publicly update any forward-looking statements. DATASOURCE: Wellstone Filters CONTACT: Wellstone Filters, Inc., http://www.wellstonefilters.com/, Investor Relations, +1-303-620-9194 Web site: http://www.wellstonefilters.com/ http://www.corporateguestbook.com/?WLSF

Copyright